Mode
Text Size
Log in / Sign up
N/A Completed N=2,233 Randomized Other

SEARCH SAPPHIRE Phase A: A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa

HIV · Hypertension · Alcohol Drinking · Maternal Child Health
Source: ClinicalTrials.gov NCT04810650 ↗
Enrolled (actual)
2,233
Serious AEs
2.3%
Results posted
Feb 2025
Primary outcomePrimary: Prevention Coverage Defined as Percentage of Follow-up Months That the Participant Used Either PrEP or PEP — 47.5; 18.3 Percentage of months

Summary

The randomized trials in this record will assess effectiveness, fidelity and cost of prevention and treatment interventions for HIV and hypertension with the objective of informing a population-based study of multi-sectored, multi-disease interventions for HIV.

Outcome Measures

OutcomeResultp-value
PRIMARY
Prevention Coverage Defined as Percentage of Follow-up Months That the Participant Used Either PrEP or PEP
47.5; 18.3
PRIMARY
Prevention Coverage Defined as Percentage of Follow-up Months at Risk That the Participant is Protected From HIV Infection With Either PrEP or PEP
70; 29
PRIMARY
Prevention Coverage Defined as Proportion of Follow-up Months at Risk That the Participant is Protected From HIV Infection With Either PrEP or PEP
28.0; 0.5
PRIMARY
Number of Participants With Viral Suppression Defined by HIV RNA<400 Cps/ml
85; 83
PRIMARY
Percentage of Participants With Viral Suppression Defined by HIV RNA<400 Cps/ml
83; 82
PRIMARY
Number of Participants Who Linked to Hypertension Care
96; 65
PRIMARY
Percentage of Participants With Hypertension Control <140/90 mmHg
77; 51

Eligibility Criteria

INDIVIDUAL LEVEL INCLUSION CRITERIA FOR COMPONENT INTERVENTIONS

PrEP/PEP at Outpatient Clinics

  • Age ≥15 years
  • HIV-negative
  • Current or anticipated risk for HIV-infection

PrEP/PEP at Antenatal Clinics

  • Age ≥15 years
  • HIV-negative
  • Current or anticipated risk for HIV-infection

PrEP/PEP at Community Households

  • Age > 15 years
  • HIV-negative
  • Current or anticipated risk for HIV-infection

Mobility Dynamic Treatment Intervention

  • Age ≥15 years
  • HIV-positive
  • HIV RNA non-suppression (>400 c/mL in the prior 12 months) or missed 2 visits in past 12 months or missed 2 visits in past 12 months or no VL measured in past 12 months
  • Travel outside the community ≥2 times in past 12 months
  • Enrolled or new to care in a study clinic

Healthy Living Intervention for Heavy Alcohol Users

  • Age ≥18 years
  • HIV-positive
  • HIV RNA non-suppression (>400 c/mL in the prior 12 months) or missed clinic visits (>2 weeks or 90 days from last scheduled clinic visit) within past 6 months
  • Heavy alcohol use per AUDIT-C tool (scores of ≥4 for men, and ≥3 for women)
  • Enrolled or new to care in a study clinic

Hypertension Linkage Intervention

  • Age ≥25 years
  • Blood pressure ≥140/90 mmHg on three repeated measurements during community-based hypertension screening
  • Resident (by self-report) within catchment area of referral health center

Community Hypertension Intervention

  • Age >=40
  • Blood pressure ≥160/100 on average of 2nd and 3rd measurements at initial screening
  • Sustained blood pressure elevation to ≥140/90 at initial clinic enrollment visit

INDIVIDUAL LEVEL EXCLUSION CRITERIA FOR COMPONENT INTERVENTIONS

PrEP/PEP at Outpatient Clinics

  • <15 years of age
  • Unable to provide consent or parental co-consent as per country guidelines
  • Participation in another Phase A RCT intervention component

PrEP/PEP at Antenatal Clinics

  • <15 years of age
  • unable to provide consent or parental co-consent as per country guidelines
  • Participation in another Phase A RCT intervention component

PrEP/PEP at Community Households

  • <15 years of age
  • unable to provide consent or parental co-consent as per country guidelines
  • Participation in another Phase A RCT intervention component

Mobility Dynamic Treatment intervention

  • <15 years of age
  • Participation in another Phase A RCT intervention component

Healthy Living Intervention for Heavy Alcohol Users

  • <18 years of age
  • Participation in another Phase A RCT intervention component
  • No access to mobile phone

Hypertension Linkage Intervention

  • <25 years of age
  • Plan to out-migrate from the catchment area of referral health center within 30 days of screening visit
  • Already engaged in hypertensive care (by self-report)
  • Blood pressure measure of ≥180/110 mmHg during screening symptoms of hypertensive emergency

Community Hypertension Intervention

  • Pregnancy
  • Co-morbidities that preclude home monitoring
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04810650). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search